Table 3.
Age- and Multivariate-Adjusted Hazard Ratios for Specific Alcoholic Beverage Use and Incident Hearing Loss
Beverage and Frequency of Use | Cases | Person-years | Age-adjusted Hazard Ratio (95% CI) | Multivariate-adjusted Hazard Ratio* (95% CI) |
---|---|---|---|---|
Beer | ||||
<1/month | 1629 | 175029 | 1.00 (ref) | 1.00 (ref) |
1/mo–1/wk | 1089 | 118953 | 1.04 (0.96–1.12) | 1.01 (0.92–1.10) |
2–4/wk | 386 | 47893 | 0.98 (0.88–1.10) | 0.94 (0.83–1.06) |
5/wk–1/d | 204 | 26935 | 0.95 (0.82–1.10) | 0.92 (0.79–1.08) |
>1/d | 84 | 10995 | 0.99 (0.80–1.23) | 0.98 (0.78–1.23) |
Red Wine | ||||
<1/month | 1741 | 197492 | 1.00 (ref) | 1.00 (ref) |
1/mo–1/wk | 1018 | 119240 | 0.98 (0.91–1.06) | 0.96 (0.87–1.06) |
2–4/wk | 408 | 39503 | 1.10 (0.98–1.22) | 1.02 (0.90–1.16) |
5/wk–1/d | 178 | 19048 | 0.94 (0.80–1.09) | 0.93 (0.78–1.10) |
>1/d | 45 | 4960 | 0.91 (0.67–1.22) | 0.89 (0.66–1.21) |
White Wine | ||||
<1/month | 1455 | 166156 | 1.00 (ref) | 1.00 (ref) |
1/mo–1/wk | 1301 | 148984 | 1.04 (0.96–1.12) | 1.04 (0.95–1.14) |
2–4/wk | 438 | 43222 | 1.19 (1.07–1.32) | 1.19 (1.05–1.35) |
5/wk–1/d | 146 | 16803 | 1.07 (0.79–1.45) | 1.01 (0.84–1.21) |
>1/d | 43 | 4553 | 1.02 (0.80–1.81) | 1.07 (0.78–1.46) |
Wine, combined | ||||
<1/month | 1225 | 140550 | 1.00 (ref) | 1.00 (ref) |
1/mo–1/wk | 1251 | 145216 | 1.02 (0.94–1.10) | 1.01 (0.93–1.10) |
2–4/wk | 584 | 58478 | 1.12 (1.02–1.24) | 1.14 (1.02–1.27) |
5/wk–1/d | 280 | 30357 | 0.98 (0.86–1.12) | 0.99 (0.86–1.14) |
>1/d | 83 | 9079 | 0.97 (0.78–1.22) | 0.97 (0.77–1.22) |
Liquor | ||||
<1/month | 1658 | 196097 | 1.00 (ref) | 1.00 |
1/mo–1/wk | 804 | 92300 | 1.07 (0.98–1.17) | 1.06 (0.97–1.17) |
2–4/wk | 388 | 42152 | 1.07 (0.95–1.19) | 1.02 (0.91–1.15) |
5/wk–1/d | 356 | 32819 | 1.14 (1.02–1.28) | 1.09 (0.96–1.23) |
>1/d | 205 | 18063 | 1.15 (0.99–1.33) | 1.09 (0.93–1.27) |
Adjusted for age, body mass index, physical activity, folate, vitamin B12, smoking, hypertension, diabetes, profession, race, hypercholesterolemia, cardiovascular disease, gout, furosemide use, aspirin use, nonsteroidal anti-inflammatory use, and acetaminophen use